TY  - JOUR
AU  - Abuin Martínez, Cristina
AU  - Vidal Casado, Rebeca
AU  - Gutiérrez López, María Dolores
AU  - Pérez Hernández, Mercedes
AU  - O'Shea Gaya, María Esther
AU  - Giménez Gómez, Pablo
AU  - Morales Puerto, Nuria
AU  - O'Shea Gaya, María Esther
AU  - Colado Megías, María Isabel
PY  - 2021
DO  - 10.1016/j.neuropharm.2021.108490
SN  - 0028-3908
UR  - https://hdl.handle.net/20.500.14352/112141
T2  - Neuropharmacology
AB  - 3,4-Methylenedioxymethamphetamine (MDMA) is an amphetamine derivative that has been shown to produce serotonergic damage in the brains of primates, including humans, and of rats. Tryptophan, the precursor of serotonin, is primarily degraded through...
LA  - eng
M2  - 1
PB  - Elsevier
KW  - MDMA
KW  - Kynurenine
KW  - Tryptophan
KW  - 2,3-dioxygenase
KW  - Aryl hydrocarbon receptors
KW  - Neurotoxicity
KW  - 3,3′-Diindolylmethane
TI  - Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor
TY  - journal article
VL  - 187
ER  -